CompanyGraph
SenseTime Group Inc.
0020 · HKEX · China
Price data from its SNTMF listing on OTC, quoted in USD
sensetime.comFinancials as of FY2025
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleLevered free cash flow is -$505.54M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 1.85: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
81.99BHKD10.45B · vs all stocks (USD)
Revenue (TTM)
5.84BCNY744.02M · vs all stocks (USD)
Profit Margin
-35.22%Beta
1.63xvs all stocks
52-Week Change
-16.29%vs all stocks
Market Capitalization
81.99BHKD10.45B · vs all stocks (USD)
Enterprise Value
60.27BHKD7.68B · vs all stocks (USD)
Forward P/E
-270.15xPrice to Sales (TTM)
11.84xPrice to Book (MRQ)
1.90xEnterprise to Revenue
10.33xEnterprise to EBITDA
-20.76xProfit Margin
-35.22%Operating Margin
-52.40%Return on Assets (TTM)
-5.98%Return on Equity (TTM)
-7.03%Revenue (TTM)
5.84BCNY744.02M · vs all stocks (USD)
Revenue per Share (TTM)
0.1350CNYUpdated Aug 19, 2026Quarterly Revenue Growth
30.70%Gross Profit (TTM)
2.39BCNY305.11M · vs all stocks (USD)
EBITDA (TTM)
-2.90BCNY-370.07M · vs all stocks (USD)
Net Income (TTM)
-2.06BCNY-262.01M · vs all stocks (USD)
Operating Cash Flow (TTM)
-350.46MCNY-44.68M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-3.97BCNY-505.54M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00HKDUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
341.94MCNYFY2025 · Dec 31, 2025Revenue
5.01BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.96BCNYFY2025 · Dec 31, 2025Gross Profit
2.06BCNYFY2025 · Dec 31, 2025Operating Income
-3.09BCNY-458.66M · vs all stocks (USD)
Pre-tax Income
-1.66BCNYFY2025 · Dec 31, 2025Income Tax Expense
122.40MCNYFY2025 · Dec 31, 2025Net Income
-1.78BCNYFY2025 · Dec 31, 2025EBIT
-1.46BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-1.74BCNYFY2025 · Dec 31, 2025Research & Development
3.78BCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.79BCNYFY2025 · Dec 31, 2025Non-operating Interest Income
257.77MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
201.25MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0500CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
37.09BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
37.09BSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
16.07MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-1.10BCNYFY2025 · Dec 31, 2025Free Cash Flow
-4.36BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
10.89BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.66BCNYFY2025 · Dec 31, 2025Stock-based Compensation
292.49MCNYFY2025 · Dec 31, 2025Other Non-cash Items
107.32MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
154.24MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
6.33MCNYFY2025 · Dec 31, 2025Capital Expenditures
-3.26BCNYFY2025 · Dec 31, 2025Net Intangibles (CF)
-88.79MCNYFY2025 · Dec 31, 2025Net Acquisitions
-227.50MCNYFY2025 · Dec 31, 2025Purchase of Investments
-10.34BCNYFY2025 · Dec 31, 2025Sale of Investments
10.15BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-3.68BCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.25BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-2.45BCNYFY2025 · Dec 31, 2025Common Stock Repurchase
0.00CNYFY2025 · Dec 31, 2025Other Financing Charges
397.67MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
5.91BCNYFY2025 · Dec 31, 2025Shares Outstanding
40.42BSharesUpdated Aug 19, 2026Float Shares
30.56BSharesUpdated Aug 19, 2026% Held by Insiders
23.01%vs all stocks
% Held by Institutions
22.95%vs all stocks
Total Cash (MRQ)
15.99BCNY2.04B · vs all stocks (USD)
Total Cash per Share (MRQ)
0.3400CNYUpdated Aug 19, 2026Total Debt (MRQ)
6.94BCNY884.73M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2203xCurrent Ratio (MRQ)
3.28xBook Value per Share (MRQ)
0.7692CNYUpdated Aug 19, 2026Total Assets
38.91BCNY5.77B · vs all stocks (USD)
Total Current Assets
18.78BCNYFY2025 · Dec 31, 2025Total Liabilities
11.84BCNYFY2025 · Dec 31, 2025Total Non-current Assets
20.12BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
6.11BCNYFY2025 · Dec 31, 2025Total Current Liabilities
5.73BCNYFY2025 · Dec 31, 2025Cash
10.89BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
10.89BCNYFY2025 · Dec 31, 2025Other Short-term Investments
2.85BCNYFY2025 · Dec 31, 2025Accounts Receivable
2.51BCNYFY2025 · Dec 31, 2025Inventory
248.12MCNYFY2025 · Dec 31, 2025Accounts Payable
682.00MCNYFY2025 · Dec 31, 2025Short-term Debt
2.08BCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.23BCNYFY2025 · Dec 31, 2025Long-term Debt
3.89BCNYFY2025 · Dec 31, 2025Common Stock (Book)
7.00KCNYFY2025 · Dec 31, 2025Retained Earnings
-58.68BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
27.06BCNY4.01B · vs all stocks (USD)
52-Week Low
1.23HKDUpdated Aug 19, 202652-Week High
2.94HKDUpdated Aug 19, 202652-Week Change
-16.29%vs all stocks
Beta
1.63xvs all stocks
50-Day MA
1.42HKDUpdated Aug 19, 2026200-Day MA
1.97HKDUpdated Aug 19, 2026Avg 10-Day Volume
520.11MSharesUpdated Aug 19, 2026Avg 30-Day Volume
497.71MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.0600CNYUpdated Aug 19, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.85: grey zoneSignificant
Altman Z-Score: 1.85
High structural barrier to entryNotable
Barrier to Entry: 0.71
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Levered free cash flow is -$505.54M, lower than 95% of all stocks globallySignificant
Levered free cash flow (USD): -505,543,584.36Global P5: -209,187,555.994
Market cap is $10.45B, above the global median of $1.18BNotable
Market cap (USD): 10,452,772,581.794Global Median: 1,179,398,897.704
Revenue is $744.02M, above the global median of $534.05MNotable
Revenue (USD): 744,023,721.341Global Median: 534,052,387.958
Companies that share the same coordination system — how they create, deliver, or capture value.
Xero Limited
Tier 1ProductionRecurring-Revenue Lock-InInterfaceRule
Bentley Systems, Incorporated Class B
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Uipath Inc.
Tier 1ProductionRecurring-Revenue Lock-InInterfaceSenseMaking
360 Security Technology Inc.
Tier 1ProductionRecurring-Revenue Lock-InRuleInterface
10x Genomics Inc.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Nemetschek SE
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingInterface
Manhattan Associates Inc.
Tier 1ProductionRecurring-Revenue Lock-InFlowSenseMaking
Elastic N.V.
Tier 1ProductionRecurring-Revenue Lock-InFlowSenseMaking
Appfolio Inc.
Tier 1ProductionRecurring-Revenue Lock-InFlowInterface
Empyrean Technology Co., Ltd.
Tier 1ProductionRecurring-Revenue Lock-InSenseMakingFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Gundogdu Gida Sut Urunleri Sanayi ve Ticaret A.S.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Kangwon Energy Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated